Austrianova Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 6

Austrianova General Information

Description

Developer of a cell encapsulation technology intended to protect, isolate, store and transport human and animal cells. The company's offerings include the utilization of a proprietary living-cell encapsulation technology for mammalian and bacterial cells which is designed to protect the encapsulated cells from rejection by the immune system by allowing the cells to be transported, stored and implanted at specific sites in patients, thereby enabling doctors and healthcare organizations to deliver strong cells and medicine in patients with weak immune systems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Primary Office
  • The Gemini, Singapore Science Park 2
  • Suite 03-15, 41 Science Park Road
  • Singapore, 117610
  • Singapore
+65 6779 0000

Austrianova Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Austrianova Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 07-Jul-2021 000.00 Completed Generating Revenue
3. Later Stage VC 22-Apr-2021 00000 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 05-Jun-2007 $47.2M $88.6M Completed Generating Revenue
1. Early Stage VC $41.4M $41.4M Completed Startup
To view Austrianova’s complete valuation and funding history, request access »

Austrianova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cell encapsulation technology intended to protect, isolate, store and transport human and animal cells. T
Biotechnology
Singapore, Singapore
9 As of 2021
000.00
0000000000 0 000.00

0000 000

r adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
0000000000000
Cambridgeshire, United Kingdom
00 As of 0000
00.000
0000000 0000 00.000

0000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e
0000 000000000
Farmington, CT
00 As of 0000
00.000
0000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Austrianova Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axol Biosciences Private Equity-Backed Cambridgeshire, United Kingdom 00 00.000 0000000 0000 00.000
0000000 Venture Capital-Backed Farmington, CT 00 00.000 0000000000 00.000
00000 0000000 0000 Formerly VC-backed San Diego, CA 00 000.00 00000000000 000.00
0000000000 0000000 Formerly PE-Backed Beit-Haemek, Israel 000 0000 000000&0 0000
0000000 Formerly VC-backed Irvine, CA 00 00000 000000 - 000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Austrianova Patents

Austrianova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201408233-D0 Use of polyanionic composition Ceased 09-May-2014 000000000
US-20170173158-A1 Use of a polyanionic composition Abandoned 09-May-2014 000000000
EP-3140347-B1 Use of a polyanionic composition Active 09-May-2014 000000000
EP-3140347-A4 Use of a polyanionic composition Granted 09-May-2014 000000000
EP-3140347-A1 Use of a polyanionic composition Granted 09-May-2014 A61K47/36

Austrianova Executive Team (7)

Name Title Board Seat Contact Info
Brian Salmons Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Pierre Faddoul Chief Financial Officer
Walter Gunzburg Co-Founder, Chief Technology Officer & Chairman
Rahul Pawa Chief Production Officer and Head of Production
John Dangerfield Ph.D Chief Operating Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Austrianova Board Members (2)

Name Representing Role Since
Brian Salmons Ph.D Austrianova Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Walter Gunzburg Austrianova Co-Founder, Chief Technology Officer & Chairman 000 0000
To view Austrianova’s complete board members history, request access »

Austrianova Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Austrianova Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GLOCALINK Singapore Venture Capital Minority 000 0000 000000 0
Real Tech Holdings Venture Capital Minority 000 0000 000000 0
Global Emerging Markets PE/Buyout Minority 000 0000 000000 0
AT Treuhand Corporation Minority 000 0000 000000 0
Omni Technology Invest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »